A- A A+

Schweiz. Über 700 Aargauer in Drogen-Programm, doch wer kümmert sich um alte Süchtige?

(…) Heute wird davon ausgegangen, dass Heroinabhängige im Normalfall dauerhaft substituiert bleiben. Das stellt die Gesellschaft vor neue Herausforderungen. Wer soll sich um die alternden Süchtigen kümmern, wenn sie auf Pflege angewiesen sind und nicht mehr täglich ihr Medikament oder das Heroin in einer Abgabestelle beziehen können? Im Aargau waren 2018 acht Männer im Substitutionsprogramm älter als 65 Jahre – in den nächsten Jahren dürften es mehr werden. Viel Zeit, eine Lösung zu finden, bleibt also nicht. «Wer jahrelang abhängig war, ist körperlich 10 bis 15 Jahre älter», sagt Martin Ooms, Teamleiter des Ambulatoriums für Substitutionsbehandlung der PDAG. Er geht deshalb davon aus, dass in rund fünf bis zehn Jahren Bedarf für solche Angebote besteht. Im Kanton Aargau gebe derzeit keine entsprechenden Betreuungsangebote, sagt er. (Aargauer Zeitung, Schweiz, 06.03.2020)


Practicing What We Preach - Ending Physician Health Program Bans on Opioid-Agonist Therapy.

Beletsky L, Wakeman SE, Fiscella K.

N Engl J Med. 2019 Aug 29;381(9):796-798. doi: 10.1056/NEJMp1907875. 


Opioid and Polydrug Use Among Patients in Opioid Maintenance Treatment.

Carlsen SL, Lunde LH, Torsheim T.

Subst Abuse Rehabil. 2020 Jan 29;11:9-18. doi: 10.2147/SAR.S221618. 


Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa.

Scheibe A, Shelly S, Gerardy T, von Homeyer Z, Schneider A, Padayachee K, Naidoo SB, Mtshweni K, Matau A, Hausler H, Marks M.

Addict Sci Clin Pract. 2020 Feb 21;15(1):13. doi: 10.1186/s13722-020-00186-7.


Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.

Huhn AS, Hobelmann JG, Strickland JC, Oyler GA, Bergeria CL, Umbricht A, Dunn KE.

JAMA Netw Open. 2020 Feb 5;3(2):e1920843. doi: 10.1001/jamanetworkopen.2019.20843.


Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in U.S. healthcare settings.

Pro G, Zaller N (2020) 

PLoS ONE 15(2): e0228755. doi.org/10.1371/journal.pone.0228755


Schweiz. Die Polizei wollte Zürcher Zustände im Aargau verhindern

Urs Winzenried und Kurt Roth haben die Auswirkungen der Drogenwelle auf den Aargau aus unterschiedlichen Perspektiven miterlebt. Urs Winzenried als Chef der Kriminalpolizei, Kurt Roth zuerst als Therapeut und später als Geschäftsleiter der Stiftung für Sozialtherapie. (Aargauer Zeitung, 15.02.2020)


Frequency of health‐care utilization by adults who use illicit drugs: a systematic review and meta‐analysis.

Lewer, D., Freer, J., King, E., Larney, S., Degenhardt, L., Tweed, E. J., Hope, V. D., Harris, M., Millar, T., Hayward, A., Ciccarone, D., and Morley, K. I. ( 2020) 

Addiction, doi.org/10.1111/add.14892.


Seychellen. Addiction in paradise: Seychelles battles heroin crisis

On a plain suburban street in Seychelles, far from the idyllic coastline and luxury resorts pampering honeymooners and paradise-seekers, heroin addicts queue anxiously for their daily dose of methadone. 

It is a scene few outsiders would associate with the tropical nirvana adrift in the Indian Ocean, and one rarely, if ever, glimpsed by tourists as they shuttle from the airport to five-star luxury on white-sand beaches.

But life for many Seychellois is far from picture perfect: the tiny archipelago nation is battling what officials say are the world's highest rates of heroin addiction. (MedicalXpress, USA, 20.02.2020)


Schweiz. Überleben nach dem Letten: Was ist aus den Drogensüchtigen aus dem Aargau geworden?

Markus, Thomas und Daniel (Namen geändert) pendelten regelmässig aus dem Aargau nach Zürich auf den Platzspitz oder Letten, um sich dort mit Drogen einzudecken. (Aargauer Zeitung, Schweiz, 21.02.2020)


UK. Inside the Middlesbrough clinic where heroin users get a 'last chance

Sitting in one of four booths, looking at himself in the mirror under a bright light, James injects himself with diamorphine - pharmaceutical heroin. (BBC, UK, 24.02.2020)


Private Coverage of Methadone in Outpatient Treatment Programs

Daniel Polsky, Samantha Arsenault, and Francisca Azocar

Psychiatric Services 0 0:0, doi.org/10.1176/appi.ps.201900373


USA. Lawmakers Urge DEA to Move on Mobile Vans, Telemedicine

Congress is getting annoyed with the stalling by the Drug Enforcement Administration (DEA) on mobile vans and telemedicine for treatment for opioid use disorder (OUD).  (ATForum, USA, 24.02.2020)


Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug-related poisoning deaths? A retrospective-cohort study.

Durand L, O'Driscoll D, Boland F, Keenan E, Ryan B, Barry J, Bennett K, Fahey T, Cousins G.

Addiction. 2020 Feb 7. doi: 10.1111/add.15004. 



Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.

Williams AR, Samples H, Crystal S, Olfson M.

Am J Psychiatry. 2020 Feb 1;177(2):117-124. doi: 10.1176/appi.ajp.2019.19060612. 


Reported Heroin Use, Use Disorder, and Injection Among Adults in the United States, 2002-2018.

Han B, Volkow ND, Compton WM, McCance-Katz EF. 

JAMA. 2020;323(6):568–571. doi:10.1001/jama.2019.20844



Routes of non-traditional entry into buprenorphine treatment programs.

Champagne-Langabeer T, Swank MW, Langabeer JR 2nd.

Subst Abuse Treat Prev Policy. 2020 Jan 20;15(1):6. doi: 10.1186/s13011-020-0252-z. 


A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use.

Wiercigroch D, Sheikh H, Hulme J.

Subst Abuse Treat Prev Policy. 2020 Jan 13;15(1):4. doi: 10.1186/s13011-019-0250-1.


Design of a randomized controlled trial to Link Infectious and Narcology Care (LINC-II) in St. Petersburg, Russia.

Gnatienko N, Lioznov D, Raj A, Blokhina E, Rosen S, Cheng DM, Lunze K, Bendiks S, Truong V, Bushara N, Toussova O, Quinn E, Krupitsky E, Samet JH.

Addict Sci Clin Pract. 2020 Jan 13;15(1):1. doi: 10.1186/s13722-020-0179-8.


USA. After Opioid Overdose, Most Young People Aren’t Getting Addiction Treatment

Drug overdoses continue to take far too many lives, driven primarily by the opioid crisis (though other drugs, such as methamphetamine and cocaine, are also major concerns). While NIH’s Helping to End Addiction Long-term (HEAL) Initiative is taking steps to address this terrible crisis, new findings serve as another wake-up call that young people battling opioid addiction need a lot more assistance to get back on the right track.

In a study of more than 3,600 individuals, aged 13-22, who survived an opioid overdose, an NIH-funded team found that only about one-third received any kind of follow-up addiction treatment [1]. Even more troubling, less than 2 percent of these young people received the gold standard approach of medication treatment. (National Institutes of Health, USA, 28.01.2020)


What constitutes effective problematic substance use treatment from the perspective of people who are homeless? A systematic review and meta-ethnography.

Carver, H., Ring, N., Miler, J. et al. 

Harm Reduct J 17, 10 (2020). doi.org/10.1186/s12954-020-0356-9


Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.

Wakeman SE, Larochelle MR, Ameli O, et al. 

JAMA Netw Open. 2020;3(2):e1920622. doi:10.1001/jamanetworkopen.2019.20622


Quality of life and well-being from the perspective of patients on opioid agonist maintenance treatment: study protocol for a systematic review of qualitative research and a scoping review of measures.

Solà I, Trujols J, Ribalta E, Alcaraz S, Robleda G, Selva Olid C, Pérez de Los Cobos J.

Syst Rev. 2019 Dec 1;8(1):299. doi: 10.1186/s13643-019-1237-8.


Kanada. Vancouver health agency floats $6 million take-home drug plan for addicts

 Push for 'safe supply' of drugs mirrors fight to open Insite drug injection site (Vancouver Courier, Kanada, 27.01.2020)


USA. Advanced practice registered nurses to have a greater role in national response to opioid epidemic

As we enter a new year and a new decade, many states have enacted legislation affecting the roles of advanced practice registered nurses (APRNs) in terms of practice authority, reimbursement, and prescriptive authority, according to the 32nd Annual Legislative Update in the January issue of The Nurse Practitioner. (MedicalXpress, 24.01.2020)


USA. A look inside the Olympia clinic serving hundreds of people battling opioid addiction 

If you hit rock bottom, what would it take to pull you back up? What if the force that pulled you down was a chemical dependency you’d been facing for decades?

Sean Allen and hundreds of locals struggling with opioid use disorder may have found their answer to that question in a small, bustling walk-in clinic that opened about a year ago in downtown Olympia. (theolympian.com, USA. 29.12.2019)


USA. Walk-in Clinics for Opioid Addiction Offer Meds First, Fast

In St. Louis, Seattle and San Francisco, people with opioid addictions can start medication on their first day of treatment. Early research suggests the approach can change lives. But it will be a tough sell elsewhere: Nearly two-thirds of U.S. treatment centers don’t offer anti-addiction drugs and there’s resistance to easy access. (AT Forum, USA. 19.12.2019)


USA. How Philly plans to combat the nation’s worst big-city opioid crisis in 2020

Philadelphia is home to the worst urban opioid crisis in America. More than 3,000 people have died of drug overdoses here in the last three years, and the city health department estimates that tens of thousands of Philadelphians are addicted to opioids.

As the epidemic has worsened, city officials, hospitals, and outreach workers have scrambled to address a complicated public health crisis with few easy answers. (The Philadelphia Inquirer, USA, 21.02.2020)


Self-Rated Physical Health and Unmet Healthcare Needs among Swedish Patients in Opioid Substitution Treatment.

Troberg K, Håkansson A, Dahlman D.

J Addict. 2019 Apr 15;2019:7942145. doi: 10.1155/2019/7942145. 


No excuses left to delay opioid agonist treatment roll-out.

Malyuta R, Krausz RM.

Lancet HIV. 2019 Dec 23. pii: S2352-3018(19)30409-6. doi: 10.1016/S2352-3018(19)30409-6.